Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Peptonic Medical

0,00 SEK

0,00 %

Mindre end 1K følgere

PMED

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
0,00 %
-11,11 %
-19,19 %
-1,23 %
+11,11 %
-59,60 %
-98,28 %
-99,76 %
-99,90 %

Peptonic Medical is a biomedical company that conducts research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to offer treatments for women-specific diseases and medical conditions. For example, hormone-free products are being developed for the treatment of vaginal atrophy and vaginal dryness. Peptonic Medical has its headquarters in Bromma.

Læs mere
Markedsværdi
33 mio. SEK
Aktieomsætning
25,45 t SEK
Omsætning
26,89 mio.
EBIT %
-218,11 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
27.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelsefor 10 timer siden

PEPTONIC Medical AB: Peptonic Medical AB announces outcome of the rights issue

Peptonic Medical
Selskabsmeddelelsefor 21 timer siden

PEPTONIC Medical AB: Peptonic Medical AB changes date for publication of year-end report

Peptonic Medical
Selskabsmeddelelse23.1.2026, 07.30

PEPTONIC Medical AB: Last day of trading with unit rights in Peptonic's rights issue

Peptonic Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse22.1.2026, 07.30

PEPTONIC Medical AB: Peptonic Medical publishes business update following completed restructuring and ongoing rights issue

Peptonic Medical
Selskabsmeddelelse14.1.2026, 07.30

PEPTONIC Medical AB: The subscription period in Peptonic's rights issue of units starts today

Peptonic Medical
Selskabsmeddelelse13.1.2026, 09.46

PEPTONIC Medical AB: Peptonic publishes prospectus in connection with rights issue of units

Peptonic Medical
Selskabsmeddelelse6.1.2026, 12.15

PEPTONIC Medical AB: Peptonic Medical announces indicative timetable for the rights issue

Peptonic Medical
Selskabsmeddelelse23.12.2025, 14.38

PEPTONIC Medical AB: Peptonic Medical AB. Corporate reconstruction formally concluded following dismissal decision

Peptonic Medical
Selskabsmeddelelse23.12.2025, 09.31

PEPTONIC Medical AB: Peptonic Medical AB's Reconstruction plan becomes legally binding and the reconstruction is concluded

Peptonic Medical
Selskabsmeddelelse16.12.2025, 07.30

PEPTONIC Medical AB: Peptonic Medical AB clarifies expected conclusion of its corporate reconstruction

Peptonic Medical
Selskabsmeddelelse28.11.2025, 14.00

PEPTONIC Medical AB: Peptonic Medical AB's reconstruction plan approved by the Uppsala District Court

Peptonic Medical
Selskabsmeddelelse27.11.2025, 11.45

PEPTONIC Medical AB: Peptonic Medical AB: Plan Hearing Held at Uppsala District Court

Peptonic Medical
Selskabsmeddelelse27.11.2025, 07.30

PEPTONIC Medical AB: Peptonic Medical AB Presents Current Sales Figures

Peptonic Medical
Selskabsmeddelelse17.11.2025, 12.45

PEPTONIC Medical AB: Correction: Peptonic Medical AB (publ) - Corporate Restructuring Continues

Peptonic Medical
Selskabsmeddelelse17.11.2025, 12.00

PEPTONIC Medical AB: Peptonic Medical: Uppsala District Court approves extension of corporate reconstruction

Peptonic Medical
Selskabsmeddelelse30.10.2025, 06.30

PEPTONIC Medical AB: Peptonic Medical receives part of first order from Joylux worth USD 126,000

Peptonic Medical
Selskabsmeddelelse27.10.2025, 13.34

PEPTONIC Medical AB: Date for the Plan Meeting in the Corporate Reorganization of Peptonic Medical AB (publ) Announced

Peptonic Medical
Selskabsmeddelelse23.10.2025, 20.24

PEPTONIC Medical AB: Reconstruction Plan in Peptonic Medical AB (publ)'s Corporate Restructuring Published

Peptonic Medical
Selskabsmeddelelse14.10.2025, 05.36

PEPTONIC Medical AB: Peptonic Medical signs strategic distribution agreement with Joylux Inc. for the USA, Canada, Mexico, and the UK

Peptonic Medical
Selskabsmeddelelse19.9.2025, 09.30

PEPTONIC Medical AB: Peptonic Medical: Uppsala District Court approves extension of corporate reconstruction

Peptonic Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.